ANNOUNCEMENT

Save $150 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Offer ends July 8..

Topic: Pozen Pharmaceuticals

AstraZeneca, Pozen file patent suit to protect arthritis drug Vimovo

AstraZeneca, Pozen file patent suit to protect arthritis drug Vimovo

April 25, 2011 11:57 am by | 0 Comments

North Carolina pharmaceutical company Pozen (NASDAQ:POZN) and drug partner AstraZeneca (NYSE:AZN) are taking legal action to block a generic competitor to osteoarthritis drug Vimovo.The companies have filed a patent infringement ... Read more